Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Founder of Binance, World’s Largest Crypto Exchange, Pleads Guilty to Anti-Money Laundering Charge
The founder of Binance, the world’s largest cryptocurrency exchange, pleaded guilty Tuesday to a felony charge that he failed to take steps to prevent money laundering as the company agreed to pay more than $4 billion following an investigation by the U.S. government.
More Than 100 Guns Stolen in Michigan After Store Manager Is Forced to Reveal Alarm Code
More than 100 handguns were stolen from a store in southwestern Michigan after the manager was held at gunpoint outside his home and forced to reveal how to turn off the alarm, authorities said Tuesday.
Stretching Your Dollar: Home Depot Returns With Annual Holiday Workshops
Home Depot Returns With Annual Holiday Workshops
Stretching Your Dollar: Budgeting for Holiday Gift Shopping
How to budget for holiday gift shopping.
Major Retailers Report Q3 Earnings
Major Retailers Report Q3 Earnings
Ford to Scale Back Production of Battery Plant
Ford to Scale Back Production of Battery Plant
Microsoft CEO Says OpenAI Governance Needs to Change
Microsoft CEO Says OpenAI Governance Needs to Change
Existing Home Sales Hit Slowest Pace in 13 Years
Existing Home Sales Hit Slowest Pace in 13 Years
Senate Committee Issues Subpoena to Live Nation, Ticketmaster
Senate Committee Issues Subpoena to Live Nation, Ticketmaster
